Logo

ABI and Solexa's Sequencing Strategies Top Most-Read GenomeWeb News Stories Last Week

Sep 25, 2006
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 22.
 
 
 
1. ABI and Solexa, Pitching Wall Street, Flesh Out Strategies for Their Sequencers (from Sept. 18)
2. Sigma-Aldrich Settles IP-Infringement Suit With Enzo (from Sept. 19)
3. Gene Logic Says Review Confirms That Genomics Unit Is Weak, Drug Repositioning Has Legs (from Sept. 22)
4. Epigenomics Licenses Health Discovery's SVM Technology for DNA Methylation Analysis (from Sept. 19)
5. Investment Bank Cuts Illumina Shares Though Says Genotyping Tech 'Best in Class' (from Sept. 18)
Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.